Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 40 opinions in the last 12 months.
Brookfield Corp (BN-T) has garnered a largely positive outlook from various experts who praise its strong management, strategic capital allocation, and diverse asset portfolio. Many analysts view it as a prime player in the private equity and alternative investment landscape, highlighting its potential for growth as liquidity conditions improve. Despite concerns about the company's exposure to real estate and the impact of its global operations, the consensus leans towards its long-term viability and performance. The stock is considered a core holding for many investors, especially those seeking long-term growth. While some experts suggest that a pullback could be imminent due to recent highs, overall sentiment remains optimistic regarding its ability to compound returns for shareholders going forward.
Loves it, wonderful management. Ran up too much, too fast. Not surprised by pullback, as all the private equity firms have. If liquidity tightens up, these guys won't be able to easily sell projects, GAAP earnings will suffer, with lower near-term cashflow and profitability.
A core holding in his Canadian dividend strategy. Incredibly well run by bright people for a long time. Sold off ~10%, but chart's done extremely well. Likes that CEO has bulk of his net worth invested in shares. Quality operation.
A year ago, people were worried about its exposure to real estate. Management owns 20% of the company, so it behooves them to do well for shareholders. Cashflow monster. Management believes its real estate holdings and potential fees are undervalued.
Are shrewd operators run by a smart CEO. Definitely buy on weakness. He wishes he knew what they own, but they seem to own everything that is great.
Indicated a move of head office to US, but doesn't have to do with tariffs. They're global, yet Canada provides only a small percentage of earnings. Management believes a move would encourage more US-based indices to include it, thereby broadening its potential shareholder base.
Phenomenal compounder. Valuation still at massive discount to US peers. Management closely aligned with shareholders and working hard to unlock value. He'd consider buying today. Unique position with capital allocation to maximize its portfolio.
He doesn't worry too much about tariffs, given BN's geographic diversity and type of operations. Great business, well-positioned long term. Valuation discount not as appealing as in the past. Be mindful of your position size.
Managed well and owns several spin-offs, baby Brookfield stocks. The stock price has moved up a lot in the past year as has the group. But it needs a pause. This is not being negative about BN-T, but the correct stock price offers no safety. You can buy this, put it away and in 5 years shares will likely be higher.
Gets you into the private equity world of alternative investments, without having to hold a mutual fund. You get more liquidity in an individual stock, along with potential growth of M&A. US deregulation should enhance M&A activity, especially if the Fed cuts another half a point. That's why it wanted to move its head office to New York.
Good allocators of capital. Only issue is that beta is higher, so stock price will be more volatile. Good hold for growth over the long term (whereas BAM provides income to retirees). Yield is 0.5%.
In an uptrend, not parabolic. Right now, it's making a normal pullback to a trendline. Good-looking stock.
Prefers this to BAM, which BN owns as well as many private assets. The CEO holds a lot of stock, too.
BN is different from the diversified BRK, and is rather very narrow, holding real estate and infrastructure very well. There's less volatility here. No, it's not a proxy for private markets.
On a sharp rally, arced off the trendline. Not sure where the 200-day MA is, but once it gets too far ahead of that it's overbought. He'd be concerned about the angle, expect a pullback. But don't argue with the trend too much.
One of his go-to names in the Brookfield suite. If you're after growth, look at BN; the parent that owns all the entities underneath, including a big chunk of BAM. Private asset markets are still quite strong. Good for the younger folks who are looking for more torque higher.
BAM deals with third-party capital that comes in. Higher dividend, but perhaps a bit less growth. Good if you're in retirement or approaching it. Neat that it's done as well as BN, but you're getting the nice dividend too.
Both in client TFSAs.
Brookfield Corp is a Canadian stock, trading under the symbol BN-T on the Toronto Stock Exchange (BN-CT). It is usually referred to as TSX:BN or BN-T
In the last year, 7 stock analysts published opinions about BN-T. 3 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Brookfield Corp.
Brookfield Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Brookfield Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
7 stock analysts on Stockchase covered Brookfield Corp In the last year. It is a trending stock that is worth watching.
On 2025-03-18, Brookfield Corp (BN-T) stock closed at a price of $74.3.
At Investor day last September it targeted expected distributed earnings at 17% compounded annually over the next 5 years. There's another possible target of 25%. It does not have much exposure to tariffs.